Suchergebnisse - "Ortiz-Cuaran, Sandra"

PubPharm (58)

1

Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Blaquier, J. | Ortiz-Cuaran, S. | Ricciuti, B. | +3

2

Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer

enthalten in: Cancer research | 2023

von Müller, N. | Lorenz, C. | Ostendorp, J. | +15

3

Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC

enthalten in: Frontiers in radiology | 2023

von Bouhamama, A. | Leporq, B. | Faraz, K. | +8

4

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Foy, J. | Karabajakian, A. | Ortiz-Cuaran, S. | +22

5

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors

enthalten in: Data in brief | 2022

von Foy, J. | Karabajakian, A. | Ortiz-Cuaran, S. | +22

6

In vitro model for resistance in oncogene-dependent tumors at the limit of radiological detectability

enthalten in: bioRxiv.org | 2022

von Müller, N. | Brägelmann, J. | Lorenz, C. | +9

7

Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Ortiz-Cuaran, S. | Swalduz, A. | Foy, J. | +32

8

How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)

enthalten in: Cancer treatment reviews | 2022

von Tabbò, F. | Pisano, C. | Mazieres, J. | +10

9

Targeting KRAS Mutant in Non-Small Cell Lung Cancer : Novel Insights Into Therapeutic Strategies

enthalten in: Frontiers in oncology | 2022

von Désage, A. | Léonce, C. | Swalduz, A. | +1

10

Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer

enthalten in: Molecular cancer research : MCR | 2022

von Leonce, C. | Saintigny, P. | Ortiz-Cuaran, S.

1
2
3
4
5
6
Nächster »
[6]